Abstract
The Vpu protein of human immunodeficiency virus type 1 (HIV-1) is a small transmembrane protein that is synthesized late in the virus life cycle. Several functions have been ascribed to the Vpu protein in the life cycle of HIV-1. First, Vpu has been shown to interact with the CD4 molecule in the rough endoplasmic reticulum (RER), the receptor for HIV-1 entry, and this interaction is thought to result in re-translocation across the RER and subsequent degradation via the proteasome pathway. Secondly, Vpu has been shown to enhance virion release from infected cells by some unknown mechanism. While much has been learned about the function of Vpu in cell culture systems, its exact role in HIV-1 pathogenesis (HIV-1 only causes disease in humans and chimpanzees) is still unknown. This has been primarily due to the lack of a suitable primate model system since vpu is found only in HIV-1 and simian immunodeficiency virus isolated from chimpanzees (SIVcpz). With the recent development of the pathogenic simian-human immunodeficiency virus (SHIV) / macaque model, in which the tat, rev, vpu and env genes of HIV-1 are expressed in the genetic background of SIV, it will now be possible to assess the role of the vpu gene product in a relevant animal model. This review will focus on the current understanding of the structure-function relationships of Vpu protein and the use of the SHIV model to assess the role of Vpu in HIV-1 pathogenesis.
Keywords: Vpu Protein, simian-human, macaque model, protein, endoplasmic reticulum
Current Genomics
Title: The Vpu Protein and its Role in HIV-1 Pathogenesis
Volume: 4 Issue: 4
Author(s): Dinesh K. Singh, Erik Pacyniak, Darcy M. Griffin and Edward B. Stephens
Affiliation:
Keywords: Vpu Protein, simian-human, macaque model, protein, endoplasmic reticulum
Abstract: The Vpu protein of human immunodeficiency virus type 1 (HIV-1) is a small transmembrane protein that is synthesized late in the virus life cycle. Several functions have been ascribed to the Vpu protein in the life cycle of HIV-1. First, Vpu has been shown to interact with the CD4 molecule in the rough endoplasmic reticulum (RER), the receptor for HIV-1 entry, and this interaction is thought to result in re-translocation across the RER and subsequent degradation via the proteasome pathway. Secondly, Vpu has been shown to enhance virion release from infected cells by some unknown mechanism. While much has been learned about the function of Vpu in cell culture systems, its exact role in HIV-1 pathogenesis (HIV-1 only causes disease in humans and chimpanzees) is still unknown. This has been primarily due to the lack of a suitable primate model system since vpu is found only in HIV-1 and simian immunodeficiency virus isolated from chimpanzees (SIVcpz). With the recent development of the pathogenic simian-human immunodeficiency virus (SHIV) / macaque model, in which the tat, rev, vpu and env genes of HIV-1 are expressed in the genetic background of SIV, it will now be possible to assess the role of the vpu gene product in a relevant animal model. This review will focus on the current understanding of the structure-function relationships of Vpu protein and the use of the SHIV model to assess the role of Vpu in HIV-1 pathogenesis.
Export Options
About this article
Cite this article as:
Singh K. Dinesh, Pacyniak Erik, Griffin M. Darcy and Stephens B. Edward, The Vpu Protein and its Role in HIV-1 Pathogenesis, Current Genomics 2003; 4 (4) . https://dx.doi.org/10.2174/1389202033490367
DOI https://dx.doi.org/10.2174/1389202033490367 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Proteomics to Identify Novel Biomarkers and Therapeutic Targets in Cardiovascular Disease
Letters in Drug Design & Discovery Guanylate Cyclase C: A Current Hot Target, from Physiology to Pathology
Current Medicinal Chemistry Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells
Current Cancer Therapy Reviews Therapeutic Drug Monitoring of Busulfan in Transplantation
Current Pharmaceutical Design Neuropharmacological Aspects of Crocus sativus L.: A Review of Preclinical Studies and Ongoing Clinical Research
CNS & Neurological Disorders - Drug Targets L-Carnitine - Metabolic Functions and Meaning in Humans Life
Current Drug Metabolism Cigarette Smoking and Hypertension
Current Pharmaceutical Design Sepsis: Links between Pathogen Sensing and Organ Damage
Current Pharmaceutical Design The Role and Modulation of the Oxidative Balance in Pregnancy
Current Pharmaceutical Design γ-Secretase as a Therapeutic Target for the Treatment of Alzheimers Disease
Current Pharmaceutical Design Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets The Bovine Basic Pancreatic Trypsin Inhibitor (Kunitz Inhibitor): A Milestone Protein
Current Protein & Peptide Science Transdermal Oxandrolone: Ex Vivo Percutaneous Absorption Study
Current Drug Delivery Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry Potential Mechanisms for Increased HIV-1 Transmission Across the Endocervical Epithelium During C. trachomatis Infection
Current HIV Research Assessing Coronary Blood Flow Physiology in the Cardiac Catheterisation Laboratory
Current Cardiology Reviews Free Radicals in Diseases and Potential Role of Phytoconstituents-A Cause with Emerging Importance
Current Chemical Biology Hijacking the Hedgehog Pathway in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry New Issues for Copper-64: from Precursor to Innovative Pet Tracers in Clinical Oncology
Current Radiopharmaceuticals Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers
Current Cancer Drug Targets